Majid, Sandralyn B.
HRN: 22-35-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2022
CEFTRIAXONE 1G (VIAL)
12/27/2022
01/03/2023
IV
2g
Q24h
Age With Moderate Dhn, Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes